Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INBS
INBS | US
2.63
USD-0.13
-4.71%
INBS | US
Loading StockChartView...
About INBS
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
23/04/2026
Close
2.63
Open
2.72
High
2.73
Low
2.60
Intelligent Bio Solutions Inc. a medical technology company developing non-invasive real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system a revolutionizing portable testing through fingerprint sweat analysis which has the potential for broader applications in additional fields; and biosensor platform for biochemistry immunology tumor markers hormones and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
View LessINBS | US
Risk
109.3
Sharpe
-0.48
Luna's Score
45/100
Recommendation
Sell
Luna says (INBS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
94.1%1 month
109.3%3 months
84.7%6 months
229.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.80
Debt to equity
0.10
Debt to assets
0.06
Ent. to EBITDA
-0.91
Ent. to rev.
0.40
PEG
-
Other Fundamentals
EBITDA
-9.31M
MarketCap
11.18M
MarketCap(USD)
11.18M
Div. yield
-
Op. margin
-386.32
Erngs. growth
-
Rev. growth
64.20
Ret. on equity
-171.71
Short ratio
0.06
Short perc.
7.03
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.74
Range1M
1.20
Range3M
8.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.56
Price X volume
178.43K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.91 | 46.09 | Cheaper |
| Ent. to Revenue | 0.40 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.80 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 84.65 | 64.12 | Riskier |
| Debt to Equity | 0.10 | -145.53 | Expensive |
| Debt to Assets | 0.06 | 0.35 | Cheaper |
| Market Cap | 11.18M | 9.70B | Emerging |
